BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 314017)

  • 1. [Hemolytic disease of the newborn caused by Rh incompatibility from the recent neonatologic viewpoint. I. Development of morbidity in the regions of Erfurt and Suhl following general induction of preventive anti-D therapy].
    Menzel K; Kobelt L; Zimmermann U; Töpke B
    Kinderarztl Prax; 1979 May; 47(5):242-50. PubMed ID: 314017
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on manifestations of Rh-related hemolytic disease of the newborn in the years 1974-1989 in the Erfurt district].
    Töpke B; Menzel K; Uhlig R; Pfister U
    Kinderarztl Prax; 1991 Apr; 59(4):111-6. PubMed ID: 1905365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Conditions of the prevention of neonatal hemolytic diseases resulting from Rh(D) incompatibility in Hungary].
    Simonovits I; Garancsy L; Böröcz I
    Orv Hetil; 1980 Apr; 121(15):875-8. PubMed ID: 6770319
    [No Abstract]   [Full Text] [Related]  

  • 4. [Current problems of blood group incompatibility in pregnancy].
    Wilken H
    Zentralbl Gynakol; 1988; 110(1):1-11. PubMed ID: 3281396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Errors in the prevention of Rh incompatibility].
    Dmoch E
    Acta Haematol Pol; 1988; 19(1-2):59-61. PubMed ID: 3149111
    [No Abstract]   [Full Text] [Related]  

  • 6. [Development of morbidity in hemolytic disease of the newborn after the introduction of immune prophylaxis at the Rostock blood exchange center from 1970 to 1980].
    Roewer J; Eggers H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(3):455-61. PubMed ID: 6194080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy and prevention of hemolytic disease of the newborn caused by the Rh factor].
    Kogoj-Bakic V
    Lijec Vjesn; 1970 Nov; 92(11):1323-31. PubMed ID: 4332439
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical aspects of prenatal prevention of rhesus incompatibility].
    Maas DH
    Beitr Infusionsther; 1992; 30():425-30. PubMed ID: 1284752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Rhesus-caused hemolytic disease of the newborn].
    Halle H
    Zentralbl Gynakol; 1971 Aug; 93(32):1079-88. PubMed ID: 4999888
    [No Abstract]   [Full Text] [Related]  

  • 10. [Practical experiences with the anti-D-IgG prevention of Rh-immunization].
    Bergmann H; Leinzinger E; Pazdernik I; Haider M
    Wien Med Wochenschr; 1969 Jan; 119(1):9-12. PubMed ID: 4975236
    [No Abstract]   [Full Text] [Related]  

  • 11. [Production of anti-Rh gamma globulin for preventive immunization].
    Hoppe HH; Krebs HJ; Mester T; Hennig W
    Munch Med Wochenschr; 1967 Aug; 109(34):1749-52. PubMed ID: 4969973
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prevention of hemolytic disease in newborn infants using anti-D immunoglobulin G].
    Mikulandra F; Perisa M; Merlak I; Kimer M; Glavadanović N
    Zentralbl Gynakol; 1989; 111(7):444-52. PubMed ID: 2786664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inoculation of animals with anti-D immunoglobulin used for prophylaxis of hemolytic disease of the newborn. I. Titers of immune antiglobulin antibodies in the blood serum of rabbits inoculated with human anti-D immunoglobulin used in serologic incompatibility in the Rh system.
    Skorczyński M; Polak S; Marzec Z; Styblińska M
    Arch Immunol Ther Exp (Warsz); 1970; 18(2):151-6. PubMed ID: 4192695
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prevention, diagnosis and therapy of Rh incompability].
    Wilken VH
    Zentralbl Gynakol; 1975; 97(14):833-45. PubMed ID: 814741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunosuppressive mechanism and effect of immunoglobulins Anti D and Anti DK (IgG) in the prevention of hemolytic disease of the newborn caused by Rh incompatibility].
    Skrzypulec ZA
    Zentralbl Gynakol; 1973 Mar; 95(12):402-10. PubMed ID: 4634158
    [No Abstract]   [Full Text] [Related]  

  • 16. [Rhesus prevention and course following amniocentesis in early pregnancy].
    Herrmann U; Sidiropoulos D
    Gynakol Rundsch; 1983; 23(3):153-9. PubMed ID: 6605902
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hemolytic disease of the newborn caused by Rh incompatibility. II. Clinical course and motality].
    Menzel K; Kobelt L; Zimmermann U; Töpke B
    Kinderarztl Prax; 1979 Jul; 47(7):347-57. PubMed ID: 573348
    [No Abstract]   [Full Text] [Related]  

  • 18. [Successes and failures in rhesus-prophylaxis].
    Speiser P
    Wien Med Wochenschr; 1983 Dec; 133(23-24):595-604. PubMed ID: 6420993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunosuppression of anti-Rh antibodies: mechanism of action and times of administration of the anti-D immunoglobulins].
    Carretti N
    Attual Ostet Ginecol; 1968; 1():181-92. PubMed ID: 4194920
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
    Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
    Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.